The Ome-Ome

In recent years the "omics" business has begun treading dangerously close to New York Times Styles section territory. Just as three people doing something you've never heard of before is enough to make for a "trend", it seems these days any collection of a dozen or so data points qualifies as an "ome."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.